Haptoglobin levels: an emerging biomarker or a bystander?
- PMID: 41077553
- DOI: 10.1093/eurjpc/zwaf653
Haptoglobin levels: an emerging biomarker or a bystander?
Conflict of interest statement
Conflict of interest: none declared.
Comment on
-
The association of haptoglobin levels and phenotype with cardiovascular disease in Type 2 diabetes: a Fenofibrate Intervention and Event Lowering in Diabetes sub-study.Eur J Prev Cardiol. 2026 Jan 6;33(1):132-142. doi: 10.1093/eurjpc/zwaf562. Eur J Prev Cardiol. 2026. PMID: 40971905 Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources
